Healthcare Roundup – Generex announces receipt of $2M for its COVID-19 vaccine development; I-Mab’s cancer therapy greenlighted in China for phase 1 trial Feb 10, 2021 Life Science
Healthcare Roundup – Bristol Myers announce new late-stage data for Opdivo/ Cabometyx combo in kidney cancer; Merck antiviral molnupiravir effective in preventing COVID-19 in lung tissue Feb 10, 2021 Life Science
Healthcare Roundup – Bristol Myers Squibb’s Inrebic nabs European Commission approval; Pfizer/BioNTech double the vaccine supply to EU Feb 8, 2021 Life Science
Healthcare Roundup – Clover shares close up nearly 6% after Chamath Palihapitiya rebukes Hindenburg report; Bristol Myers Squibb wins FDA approval for lymphoma treatment Breyanzi Feb 5, 2021 Life Science
Healthcare Roundup – Omega Health buys 24 facilities for $510M; Align Tech up 13% as analysts view Q4 2020 results favorably Feb 4, 2021 Life Science
Healthcare Roundup – Jazz to acquire GW Pharma in cash-and-stock deal valued at $7.2B; Anavex gains after favorable data from Cassava Sciences in Alzheimer’s Feb 4, 2021 Life Science
Healthcare Roundup – Pfizer runs early on schedule to supply 200M COVID vaccine doses to U.S. by May; Cassava surges after favorable trial data for simufilam in Alzheimer’s disease Feb 3, 2021 Life Science
Healthcare Roundup – Illumina surges after patent win; announces collaboration in China; BioCryst climbs after being named ‘the most undervalued stock in the market Feb 1, 2021 Life Science
Healthcare Roundup – AstraZeneca gets European nod for COVID-19 vaccine; eHealth announces $225M strategic investment from H.I.G. capital Jan 30, 2021 Life Science
Healthcare Roundup – AstraZeneca COVID-19 shot is only for those aged 18-64 in Germany, Hims & Hers Health soars after Cathie Wood’s ETF discloses stake Jan 28, 2021 Life Science
Healthcare Roundup – Lilly bamlanivimab combo therapy lowers COVID-19 hospitalizations, JNJ earnings release brightens U.S. biopharma outlook Jan 26, 2021 Life Science
Healthcare Roundup – Intuitive Surgical earns mixed reviews from analysts despite earnings beat; Amyris acquires Terasana Brand for offering clean cannabinoid consumer products Jan 22, 2021 Life Science
Healthcare Roundup – Moderna says dosing underway in Takeda-led early-stage COVID vaccine trial in Japan; Gene editors raise equity as shares climb amid investor interest Jan 21, 2021 Life Science
Healthcare Roundup – Adamis Pharma soars on Tempol IND submission for COVID-19 treatment; MindMed kicks off early stage trial for LSD-MDMA cocktail Jan 20, 2021 Life Science
Healthcare Roundup – Moderna drops as company acknowledges allergic reactions to COVID-19 shot, Eli Lilly upgraded to buy at Mizuho on positive donanemab data Jan 19, 2021 Life Science
Healthcare Roundup – COVID-19 Jabs: Israel trades data for doses; U.K. to vaccinate all adults by September；Grifols to trial new immunoglobulin therapy against COVID-19 Jan 18, 2021 Life Science
Healthcare Roundup – Norway says deaths after COVID-19 jab may be from side effects, Sorrento could nearly quadruple in value: analyst Jan 15, 2021 Life Science
Healthcare Roundup – The world will have to live with COVID forever; Gilead attributes long term growth to oncology franchise, excludes remdesivir Jan 14, 2021 Life Science
